Internal Medicine Meeting Recordings
Captured from Internal Medicine Meeting 2022, this video bundle package provides 3 hours of high-yield video content covering strategies and management options for treating substance use disorder.
To purchase for credit, ACP members pay $29 while non-members pay $59.
Note: 2022 Premium registrants or CME 170 purchasers can find this content here.
Content includes:
Outpatient Management of Opioid Use Disorder
Ann Garment, MD, FACP addresses treatment options for patients with opioid use disorder (OUD) including buprenorphine, methadone, and injectable naltrexone. Topics covering harm reduction interventions, including naloxone overdose kits, needle exchange programs, supervised injection facilities, benzodiazepine co-prescription and hepatitis C treatment are addressed within the one-hour lecture.
Treating Tobacco Users: Strategies for Success
Nancy Rigotti, MD discusses the most effective evidence-based treatments for tobacco dependence; as well as how clinicians can integrate tobacco cessation treatment into office practice, and provides recommendations regarding how patients should be counseled about the pros and cons of e-cigarettes and vaping.
When Your Medically Ill Inpatient Has Opioid Use Disorder
Teryl K. Nuckols, MD, MSHS, FACP addresses how an internist can diagnose and manage inpatient opioid withdrawal, manage pain symptoms in patients with high opioid tolerance or risk factors for abuse, and treating acute pain in patients already on medication for addiction treatment (MAT) for opioid use disorder, such as methadone, buprenorphine, or naloxone. Common barriers to initiation of MAT for opioid use disorder in the inpatient setting are also discussed, including COVID-19 effects on opioid use disorders.
CME/MOC:
Up to 3
AMA PRA Category 1 Credits ™ and MOC Points
Expires April 28, 2026
active
Cost:
Discounted to Members
Format:
Video Recordings
Product:
Internal Medicine Meeting Recordings
ACP's Internal Medicine Meeting Recording packages include video and slide presentations from a curated selection of popular and highly rated sessions delivered during or derived from the ACP Internal Medicine Meeting. Trusted, timely content in general internal medicine and the subspecialties is presented by expert faculty; CME and MOC available.
The individuals listed below have relevant financial relationships to disclose. No other individuals in control of content for this activity have anything to disclose. All relevant financial relationships have been mitigated.
Lucinda Harris, planner
Consultant: Allergen, Bausch and Lomb
Paul Mather, planner
Consultant: Novartis
Accreditation Information
The American College of Physicians is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The American College of Physicians designates each enduring material for the number of AMA PRA Category 1 Credit(s)™ listed below. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Outpatient Management of Opioid Use Disorders: 1 AMA PRA Category 1 Credit(s)™
Treating Tobacco Users: Strategies for Success: 1 AMA PRA Category 1 Credit(s)™
When Your Medically Ill Inpatient Has Opioid Use Disorder: 1 AMA PRA Category 1 Credit(s)™
Successful completion of these CME activities, which includes participation in the evaluation component, enables the participant to earn medical knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
Release Date: April 29, 2023
Termination Date: April 28, 2026